Rabaca, Mary Jane H.
HRN: 19-45-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2022
CEFUROXIME 500MG (TAB)
12/13/2022
12/20/2022
PO
1 Cap
BID
S/p Nsvd; Prom X 42 HRS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes